Summary
62 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 14% a year over the last 3 years.
- It has been profitable 6 years in a row.
What to watch
- The share price is above the Bulios Fair Price.
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 16.4 CAD for 1 CAD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (CAD)
Diluted EPS (CAD)
- Analyst estimate
Revenue fell by 8.6% a year over 5 years. Earnings per share grew by 14% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 CAD of revenue goes
- Cost of sales 39 CAD
- Sales and administration 35 CAD
- Taxes and other 2.8 CAD
- Net profit 8.8 CAD
Net profit, industry median (Insurance - Diversified) 8.3 CAD
Out of every 100 CAD of revenue, 8.8 CAD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 2.02%
- Paid out of profit
- 33%
- Raised in a row
- 4 years
You receive $3.02 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 6
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.